Actively Recruiting
Defining Parameters to Optimize Neurostimulation for the Treatment of Pediatric Depression
Led by Université de Sherbrooke · Updated on 2025-02-10
30
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research investigates different parameters of intermittent theta burst transcranial magnetic stimulation (iTBS), a type of repetitive TMS used to alter brain activity and promote brain plasticity. The study focuses on how the shape and duration of electromagnetic pulses during iTBS affect the brain's ability to reorganize itself, aiming to improve treatment methods for depression that does not respond to usual therapies. Participants will receive three different iTBS protocols, each separated by a week. The protocols involve different pulse shapes and durations: monophasic pulses, biphasic pulses, and long monophasic pulses. Each protocol uses pulses delivered at 80% of the resting motor threshold, with specific frequency and timing settings. The sequence of these protocols will be randomized for each participant. During the study, brain activity will be monitored before and after each iTBS session to measure cortical plasticity, with assessments every five minutes up to one hour post-intervention. Participants will be involved in multiple sessions with these measurements to understand the effects of each protocol. The study will also monitor participant health and any reactions throughout the process, with the total participation duration spanning several weeks due to the multiple study visits and washout periods.
CONDITIONS
Brief Title
Optimization of ITBS for Depression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 18 and 35 years old
- Be right-handed
- Be in good health
You will not qualify if you...
- Have an implant or pacemaker
- Have tinnitus
- Have a history of fainting
- Have had an epileptic seizure or have a family history of epilepsy
- Have a known neurological disease
- Be under psychotropic medication
- Have suffered from substance abuse or dependence in the last 6 months
- Have a neurostimulator
- Have a splinter or metallic implant in the head or body
- Have a cochlear implant
- Have an automated injection system implanted (insulin pump)
- Have a transdermal patch
- Have tattoos in the area to be studied
- Be pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 3 weeks
Participants receive three different intermittent theta burst stimulation (iTBS) device protocols, each separated by one week. The order of the iTBS protocols will be randomized.
3 visits (in-person), one per week for each iTBS protocol
Trial Site Locations
Total: 1 location
1
Centre de recherche du Centre hospitalier universitaire de Sherbrook
Sherbrooke, Quebec, Canada, J1H 5H3
Actively Recruiting
Research Team
S
Samantha Cote, Ph.D.
J
Jean-Francois Lepage, Ph.D.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here